BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 12950897)

  • 1. The yeast species causing fungemia at a university hospital in Riyadh, Saudi Arabia, during a 10-year period.
    Al-Hedaithy SS
    Mycoses; 2003 Sep; 46(8):293-8. PubMed ID: 12950897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distribution of Candida species among bloodstream isolates.
    Al-Jasser AM; Elkhizzi NA
    Saudi Med J; 2004 May; 25(5):566-9. PubMed ID: 15138521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Survey of fungemia cases during the past seventeen years at Teikyo University Hospital].
    Kawakami S; Ono Y; Miyazawa Y; Yamaguchi H
    Kansenshogaku Zasshi; 1998 Feb; 72(2):105-13. PubMed ID: 9545685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five-year evaluation of bloodstream yeast infections in a tertiary hospital: the predominance of non-C. albicans Candida species.
    Pereira GH; Müller PR; Szeszs MW; Levin AS; Melhem MS
    Med Mycol; 2010 Sep; 48(6):839-42. PubMed ID: 20163281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and epidemiology of Candida species causing fungemia at a Saudi Arabian hospital, 1996-2004.
    Al-Tawfiq JA
    Int J Infect Dis; 2007 May; 11(3):239-44. PubMed ID: 16859945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fungemia in non-HIV-infected patients: a five-year review.
    Anunnatsiri S; Chetchotisakd P; Mootsikapun P
    Int J Infect Dis; 2009 Jan; 13(1):90-6. PubMed ID: 18653367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candidemia in Norway (1991 to 2003): results from a nationwide study.
    Sandven P; Bevanger L; Digranes A; Haukland HH; Mannsåker T; Gaustad P;
    J Clin Microbiol; 2006 Jun; 44(6):1977-81. PubMed ID: 16757587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Emergence of Candida tropicalis as the major cause of fungaemia in India.
    Mathews MS; Samuel PR; Suresh M
    Mycoses; 2001; 44(7-8):278-80. PubMed ID: 11714062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology, species distribution and in vitro antifungal susceptibility of fungaemia in a Spanish multicentre prospective survey.
    Pemán J; Cantón E; Quindós G; Eraso E; Alcoba J; Guinea J; Merino P; Ruiz-Pérez-de-Pipaon MT; Pérez-del-Molino L; Linares-Sicilia MJ; Marco F; García J; Roselló EM; Gómez-G-de-la-Pedrosa E; Borrell N; Porras A; Yagüe G;
    J Antimicrob Chemother; 2012 May; 67(5):1181-7. PubMed ID: 22351683
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Etiological factors of fungemia in the Hospital San Martín in La Plata].
    Mestroni SC; Verna JA; Smolkin A; Bava AJ
    Rev Argent Microbiol; 2003; 35(2):106-9. PubMed ID: 12920994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ethnicity and other possible risk factors for candidemia at 3 tertiary care university hospitals in Hawaii.
    Fujitani S; Ricardo-Dukelow M; Kamiya T; Sullivan L; Low L
    Infect Control Hosp Epidemiol; 2006 Nov; 27(11):1261-3. PubMed ID: 17080389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Multicenter study of fungemia due to yeasts in Argentina].
    Rodero L; Davel G; Soria M; Vivot W; Córdoba S; Canteros CE; Saporiti A;
    Rev Argent Microbiol; 2005; 37(4):189-95. PubMed ID: 16502638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital.
    Bedini A; Venturelli C; Mussini C; Guaraldi G; Codeluppi M; Borghi V; Rumpianesi F; Barchiesi F; Esposito R
    Clin Microbiol Infect; 2006 Jan; 12(1):75-80. PubMed ID: 16460550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prevalence of Candida albicans and Candida non-albicans in clinical samples during 1999-2001].
    Mujica MT; Finquelievich JL; Jewtuchowicz V; Iovannitti CA
    Rev Argent Microbiol; 2004; 36(3):107-12. PubMed ID: 15559191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The epidemiology of hematogenous candidiasis caused by different Candida species.
    Abi-Said D; Anaissie E; Uzun O; Raad I; Pinzcowski H; Vartivarian S
    Clin Infect Dis; 1997 Jun; 24(6):1122-8. PubMed ID: 9195068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
    Tan TY; Tan AL; Tee NW; Ng LS; Chee CW
    Mycoses; 2010 Nov; 53(6):515-21. PubMed ID: 19619263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antifungal susceptibility of Candida spp. isolates from blood cultures in a five-year period (1997-2001)].
    Durán MT; Velasco D; Canle D; Moure R; Villanueva R
    Enferm Infecc Microbiol Clin; 2003 Nov; 21(9):488-92. PubMed ID: 14572381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increase in Candida parapsilosis fungemia in critical care units: a 6-years study.
    Horasan ES; Ersöz G; Göksu M; Otag F; Kurt AO; Karaçorlu S; Kaya A
    Mycopathologia; 2010 Oct; 170(4):263-8. PubMed ID: 20524154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
    Safdar A; van Rhee F; Henslee-Downey JP; Singhal S; Mehta J
    Bone Marrow Transplant; 2001 Nov; 28(9):873-8. PubMed ID: 11781648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.